Jeffrey Paley, Director at Journey Medical Corp (DERM), bought 30,000 shares at $2.97 ($89K) on 2023-09-21, disclosed to the SEC on 2023-09-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| DERM | BUY | 2023-10-10 | $45K | — | Filing → |
| ATXI | BUY | 2018-12-12 | $133K | — | Filing → |
| RTRX | SELL | 2014-08-18 | $246K | — | Filing → |